Follow The Filings

ABX Abacus Life Inc.

Financials, filed as ABACUS LIFE INC (CL A), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by ABX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ABX insider trades
  • None no insider bought on the open market
  • $1.2M sold by 3 insiders outside a trading plan
  • $2.5M sold by 3 insiders under 10b5-1 plans
  1. Matthew Ganovsky 10% owner
    Planned sale
    $176K 22,800 shares at $7.74 0.3% of stake
    Traded Sep 23 Filed Sep 23
  2. Kevin Scott Kirby 10% owner
    Planned sale
    $176K 22,745 shares at $7.74 0.2% of stake
    Traded Sep 23 Filed Sep 23
  3. Sean McNealy 10% owner
    Planned sale
    $176K 22,700 shares at $7.74 0.2% of stake
    Traded Sep 23 Filed Sep 23
  4. Sean McNealy 10% owner
    Planned sale
    $671K 80,954 shares at $8.29 0.6% of stake
    Traded Sep 18–22 Filed Sep 22
  5. Kevin Scott Kirby 10% owner
    Planned sale
    $676K 81,500 shares at $8.29 0.6% of stake
    Traded Sep 18–22 Filed Sep 22
  6. Matthew Ganovsky 10% owner
    Planned sale
    $674K 81,312 shares at $8.29 0.9% of stake
    Traded Sep 18–22 Filed Sep 22
  7. Sean McNealy 10% owner
    Sale
    $395K 38,333 shares at $10.31 0.3% of stake
    Traded Aug 3 Filed Aug 5
  8. Kevin Scott Kirby 10% owner
    Sale
    $395K 38,334 shares at $10.31 0.3% of stake
    Traded Aug 3 Filed Aug 5
  9. Matthew Ganovsky Founder
    Sale
    $20K 2,386 shares at $8.38 <0.1% of stake
    Traded Feb 18 Filed Feb 18
  10. Sean McNealy Founder
    Buy
    $498K 86,207 shares at $5.77 New stake
    Traded Jun 4, 2025 Filed Feb 18

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants, 7 share withholdings for taxes, 4 other transactions, and 2 sales to cover taxes.

Congress

No member of Congress reported trading ABX in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 2.02,8.01,9.01
8-K 7.01,9.01
8-K 7.01,8.01,9.01
10-Q
8-K 2.02,7.01,9.01
8-K 1.01,5.02,9.01
8-K 7.01,9.01
8-K 5.02,5.07,9.01
8-K 8.01,9.01
10-Q
8-K 2.02,7.01,9.01
DEFA14A
DEF 14A
8-K 5.02,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $235.24M
Gross profit $59.91M $100.55M $206.38M
Gross margin * — — 87.7%
Net income $9.52M -$23.96M $36.53M
Net margin * — — 15.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $31.78M $159.56M $69.57M
Total non-current assets * $300.05M $714.6M $832.67M
Total assets $331.83M $874.16M $902.24M
Total current liabilities $23.33M $62.47M $148.59M
Total non-current liabilities * $144.43M $388.4M $330.11M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$64.52M -$208.81M -$25.68M
Cash from investing $2.24M -$4.96M -$23.28M
Cash from financing $57.82M $320.12M -$44.87M
Net change in cash -$4.46M $106.36M -$93.83M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Period archive

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf